RUNX3 and chordoma: Other recurrent losses, observed in the present study by aCGH, involved regions carrying the tumor suppressors PTEN/10q23.31, CHEK2/22q12.1 and the transcription factor RUNX3/1p36.11, all previously described in chordomas [7].